Alterity Therapeutics Limited Made Headway

Alterity Therapeutics Limited (ATHE:NASDAQ) soared at $4.2, representing a gain of 153%. On Mon, Dec 04, 2023, ATHE:NASDAQ touched a New 2-Week High of $4.2. The stock got featured on our News Catalysts scanner on Mon, Dec 04, 2023 at 07:10 PM in the 'BIOTECH' category. From Wed, Nov 22, 2023, the stock recorded 57.14% Up Days and 62.50% Green Days

The stock spiked on Mon, Dec 04, 2023 at $5.41 with a volume of 34M+.

About Alterity Therapeutics Limited (ATHE:NASDAQ)

Prana Biotechnology Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.